ClinicalTrials.Veeva

Menu

Efficacy and Safety of the Neodymium Laser in Treatment of Urogenital Tract Diseases in Women

1

1st Federal Budgetary Healthcare Institution Volga District Medical Center

Status

Completed

Conditions

Vulvar Lichen Sclerosus
Pelvic Floor Dysfunction
Genitourinary Syndrome of Menopause

Study type

Observational

Funder types

Other

Identifiers

NCT05251220
29.10№14

Details and patient eligibility

About

Study objective: To evaluate the efficacy and safety of the Magic Max neodymium laser in the medical treatment of women with symptoms of genitourinary syndrome of menopausal, vulvar lichen sclerosus and pelvic floor muscle reduction.

Full description

Study objective: To evaluate the efficacy and safety of the Magic Max neodymium laser in the medical treatment of women with symptoms of genitourinary syndrome of menopausal, vulvar lichen sclerosus and pelvic floor muscle reduction.

Materials and methods: 60 patients with diseases of the urogenital tract were enrolled into the study; they were treated with a neodymium (ND) laser: three 20-minute sessions every 28 ± 2 days. Efficacy was assessed by means of the Female Sexual Function Index (FSFI), ICIQ-SF, PISQ-12, SF36 survey forms, and a questionnaire to identify urinary disorders at the following time points: before treatment, one month after each session and 6 months after the last procedure.

Enrollment

60 patients

Sex

Female

Ages

29 to 72 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diseases of the urogenital tract
  • symptoms of genitourinary menopausal syndrome,
  • vulvar lichen sclerosus
  • pelvic floor muscle reduction

Exclusion criteria

  • pregnancy
  • oncological diseases

Trial design

60 participants in 4 patient groups

10 women with objectively confirmed vulvovaginal atrophy
Description:
10 women with objectively confirmed vulvovaginal atrophy (genitourinary menopausal syndrome
37 women with 1-2 degree prolapse of the vaginal walls combined with stress urinary incontinence
Description:
37 women with 1-2 degree prolapse of the vaginal walls combined with stress urinary incontinence
7 with vaginal relaxation syndrome
Description:
7 with vaginal relaxation syndrome
6 with vulvar lichen sclerosus
Description:
6 with vulvar lichen sclerosus

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems